×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Gov. Hochul releases 2025-2026 COVID-19 vaccine guidance
WBNG
Governor Kathy Hochul has released New York State's 2025-2026 COVID-19 vaccine guidance.
4 hours ago
Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics?
PharmaVoice
While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.
3 days ago
Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction
Yahoo Finance
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bristol-Myers Squibb Company stands fifth among them...
2 days ago
Lingohr Asset Management GmbH Sells 36,209 Shares of BioNTech SE Sponsored ADR $BNTX
MarketBeat
Lingohr Asset Management GmbH cut its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 84.1% during the 2nd quarter,...
19 hours ago
BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial
Reuters
A next-generation cancer immunotherapy by BioNTech and partner Bristol Myers Squibb led to encouraging tumour shrinkage in a mid-stage trial...
1 week ago
BioNTech's take on iza-bren enters the clinic | ApexOnco - Clinical Trials news and analysis
Oncology Pipeline
After impressing with a me-too version of Enhertu last week, BioNTech is attempting to repeat the trick with its take on izalontamab...
1 week ago
Why BioNTech Stock Sank by More Than 7% Today
The Motley Fool
The type of vaccine it's most famous for might be cast in a very unflattering light in the very near future..
5 days ago
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose
Fierce Biotech
BioNTech and BMS have picked the pumitamig dose for the Rosetta Lung-01 phase 3 trial in first-line extensive-stage small cell lung cancer.
1 week ago
COVID: BioNTech to pay $1.2 billion over vaccine royalties
DW
COVID: BioNTech to pay $1.2 billion over vaccine royalties ... German pharmaceutical company BioNTech has agreed to pay a combined sum of more...
8 months ago
BioNTech and Pfizer strike back against GSK in London
JUVE Patent
Comirnaty manufacturers Pfizer and BioNTech are seeking a revocation of a GSK mRNA patent at the UK High Court.
1 week ago